Bob Rhatigan

Mr. Rhatigan is the CEO of Merz Aesthetics, the largest dedicated medical aesthetics business globally, where he leads company strategy and operations with a relentless focus on meeting the needs of our customers worldwide and helping to facilitate their success.
Mr. Rhatigan holds a proven track record of successful business leadership, building strong teams and developing leading brands in the medical aesthetics arena. Prior to joining Merz in 2017,
Mr. Rhatigan spent 17 years at Allergan where he completed his tenure as SVP, GM and Chief Executive of SkinMedica®.
Prior to this role, Mr. Rhatigan served as SVP of Allergan’s Facial Aesthetic business, where he led the launches and marketplace success of BOTOX® Cosmetic, JUVÉDERM® and LATISSE® in the United States.
In addition to his experience in medical aesthetics, Mr. Rhatigan has extensive leadership and product launch experience across neurosciences, medical dermatology and eye care. Prior to Allergan,
Mr. Rhatigan spent nine years at Procter & Gamble in a variety of roles of increasing responsibility in sales and marketing. Mr. Rhatigan most recently served as President and CEO of Merz
Americas.
In 2019, Mr. Rhatigan was named a PharmaVOICE 100 award winner and the “Top Aesthetics CEO” by Aesthetic Everything for the third consecutive year. Previous awards include: “Innovator in Dermatology” by the Cosmetic Surgery Forum in 2013, “Top 25 DTC Marketer” from DTC Perspectives in 2008, and “Excellence in Sales Leadership” from PDI in 2004.